17412-20-3

Basic information

• Product Name: 6-chloro-2,7-dimethyl-Imidazo[1,2-b]pyridazine
• Synonyms: 6-chloro-2,7-dimethyl-Imidazo[1,2-b]pyridazine
• CAS NO: 17412-20-3
• Molecular Formula: C8H8ClN3
• Molecular Weight: 181.625
• Mol File: 17412-20-3.mol
• Article Data: 6

Chemical Properties

• Density: 1.37±0.1 g/cm3(Predicted)
• CAS DataBase Reference: 6-chloro-2,7-dimethyl-Imidazo[1,2-b]pyridazine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-chloro-2,7-dimethyl-Imidazo[1,2-b]pyridazine(17412-20-3)
• EPA Substance Registry System: 6-chloro-2,7-dimethyl-Imidazo[1,2-b]pyridazine(17412-20-3)

Safety Data

• Hazardous Substances Data: 17412-20-3(Hazardous Substances Data)

Usage

General Description

6-Chloro-2,7-dimethyl-Imidazo[1,2-b]pyridazine, also known as clorimuron, is a chemical compound commonly used as a herbicide. It belongs to the group of imidazolinones and is specifically formulated to control a broad spectrum of grasses and broadleaf weeds in various crops, including soybeans, corn, and wheat. Clorimuron works by inhibiting the activity of acetolactate synthase, a key enzyme in the biosynthesis of branched-chain amino acids in plants, ultimately leading to their death. It is readily absorbed by the roots and foliage of target weeds and is known for its fast and effective action in controlling weed growth. However, the use of clorimuron also raises concerns about its potential impact on non-target organisms and the environment, leading to its regulation and specific guidelines for its use.

Upstream product

• 19064-64-3 3,6-dichloro-4-methylpyridazine 
• 126-38-5 1-bromo-2,2-dimethoxypropane 
• 598-31-2 1-bromoacetone 

Relevant articles and documents

COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY

The present invention provides compounds of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments.

COMPOUNDS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS

The present invention provides compounds of formula (I) (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof for use in the treatment, prevention and/or delay of progression of amyotrophic lateral sclerosis (ALS). Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments.

COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY

The present invention provides compounds of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments.